Abstract:Objective To investigate the effect of Epstein-Barr virus (EBV) infection-associated liver injury on circulating blood T lymphocyte subsets. Methods Clinical data of 56 patients diagnosed with EBV infection-related liver injury from June 2012 to August 2018 were retrospectively analyzed. Results In 56 cases of EBV infected, pure EBV infected patients were 36 cases (64.29%), EBV infected patients combined with other virus were 20 cases (35.71%), in which there were 2 cases combined with HAV (3.57%), 8 cases combined with HBV (14.29%), 1 case combined with HCV (1.79%) and 2 cases combined with coxsackie B group virus (3.57%), 3 cases combined with VZV (5.36%), 4 cases combined with HBV and VZV (7.14%). The liver injury indexes of both the pure EBV infection group and the EBV combined with other virus were significantly higher than those of the healthy control group (P?0.05). The liver injury degree of the EBV infection group was heavier than that of the EBV infection group, and the difference was statistically significant (P?0.05). The CD3+T and CD8+T subsets of the EBV combined other infection group were higher than those of the healthy control group, and the CD4+T and CD4+/CD8+T were lower than those of the healthy control group (P?0.05); the CD3+T and CD8+T of the EBV combined infection group were higher than those of the pure EBV infection group, and the CD3+T and CD4+/CD8+T were lower than those of the pure EBV infection group (P?0.05). After treatment, CD3+T and CD8+T were significantly down-regulated compared with those before treatment, and the CD4+/CD8+T was significantly up-regulated in the CD4+T and EBV combined other infection group (P?0.05), and the levels of CD3+T, CD4+T and CD8+T were higher than those in the pure EBV infection group (P?0.05). The levels of CD3+T, CD4+T, CD8+T and CD4+/CD8+T were not correlated with the EBV-DNA load before and after treatment in the pure EBV infection group and the EBV combined other infection group (P?>?0.05). Conclusions EBV infection can not only cause different degrees of liver function damage, but also cause T lymphocyte subgroup dysfunction. Paying attention to EBV virus screening is conducive to early diagnosis and early treatment.